ReviewHawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health2019
Intranasal Corticosteroids and Central Serous Chorioretinopathy: A Report and Review of the Literature.
Review in Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 8 citations in OpenAlex.
- Corticosteroid-induced central serous chorioretinopathy in a pemphigus vulgaris patient.Dermatology online journal · 2025Article
- Sleep and mood in central serous chorioretinopathy.Eye (London, England) · 2025Article
- Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: Report of two cases.JAAD case reports · 2024Article
- Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center.Drugs - real world outcomes · 2022Article
- Diagnostic and Therapeutic Challenges in a Patient with Radiation Retinopathy Complicated by Corticosteroid-Induced Central Serous Chorioretinopathy.Medicina (Kaunas, Lithuania) · 2022Article
- "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.Journal of ophthalmic inflammation and infection · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 43-year-old male with a history of allergic rhinitis on chronic intranasal corticosteroids presented with complaints of a "black band" in his right eye visual field. On examination, he had subretinal fluid and lab tests and imaging studies including optical coherence tomography (OCT) and fluorescein angiography (FA) did not show any evidence of inflammatory, degenerative, or malignant process. He was diagnosed with central serous chorioretinopathy (CSCR). Symptoms improved and the subretinal fluid resolved after the discontinuation of intranasal corticosteroid medication. Intranasal corticosteroids are rarely associated with CSCR. Patients and providers should be aware of the potential risk of vision loss caused by intranasal corticosteroids.
Indexed as
Identifiers
31049263PMC6495026W3024453719What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.